Head-to-Head

Abbott Laboratories vs. Nektar Therapeutics

ABT

Abbott Laboratories

$103.00 -0.84%

VS NKTR

Nektar Therapeutics

$30.20 -7.19%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTNKTR
Market Cap $178.39 billion $1.11 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTNKTR
Dividend Yield 2.45% —

ABT and NKTR split the dividend factors evenly.

Risk & Sentiment

ABTNKTR
Short Interest 0.57% 31.24%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, NKTR overview, NKTR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.